Tumor necrosis factor and lymphotoxin-alpha genetic polymorphisms and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study of patients treated with BFM therapy

Peer Review reports

Original Submission
9 Nov 2000	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
Resubmission - Version 3
	Submitted	Manuscript version 3
2 Apr 2001	Author responded	Author comments - Martin Stanulla
Resubmission - Version 4
2 Apr 2001	Submitted	Manuscript version 4
Publishing
10 Apr 2001	Editorially accepted
10 Apr 2001	Article published	10.1186/1471-2326-1-2

Back to article page